NASDAQ:MYGN | Free Cash Flow | MYRIAD GENETICS INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2009-06-30 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$15.7M
2025-12-31$10.6M
2025-03-31-$16.3M
2024-12-31$6.6M
2024-03-31-$18.6M
2023-12-31-$54.7M
2023-03-31-$33.2M
2022-12-31-$7.3M
2022-03-31-$46.5M
2021-12-31-$9.5M
2021-03-31$71.8M
2020-09-30-$59.3M
2020-06-30$30M
2020-03-31$16.8M
2019-09-30$15.8M
2019-06-30$31.5M
2018-09-30$7.8M
2018-06-30$47.9M
2017-09-30$23.5M
2017-06-30$36.6M
2016-09-30-$2.9M
2016-06-30$38.5M
2015-09-30$29.8M
2015-06-30$51M
2014-09-30$7M
2014-06-30$40.92M
2013-09-30$90.48M
2013-06-30$63M
2012-09-30$51.36M
2012-06-30$41.7M
2011-09-30$31.82M
2011-06-30$36.37M
2010-09-30$29.3M
2010-06-30$46.52M
2009-09-30$23.18M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$1.8M
2024-12-31-$8.7M
2023-12-31-$110.9M
2022-12-31-$106.3M
2021-12-31$18.6M
2020-06-30$60.7M
2019-06-30$83.7M
2018-06-30$115.9M
2017-06-30$106.2M
2016-06-30$166.3M
2015-06-30$140.5M
2014-06-30$190.2M
2013-06-30$173.87M
2012-06-30$141.8M
2011-06-30$130.83M
2010-06-30$155.09M
2009-06-30$84.04M